North America Medicated Shampoo Market Databank
The Medicated Shampoo market was valued at $13,500.0 Million in 2020, and is projected to reach $21,613.1 Million by 2029 growing at a CAGR of 5.41% from 2021 to 2029. Dandruff & Sebborheic Dermatis segment is expected to be the highest contributor to this market, with $4,975.2 Million in 2020, and is anticipated to reach $7,940.7 Million by 2029, registering a CAGR of 5.37%. Tinea Captis segment is anticipated to reach $2,525.0 Million by 2029 with the highest CAGR of 5.58%. Dandruff & Sebborheic Dermatis and Allergic Reactions segments collectively expected to account for about 57.9% share of the Medicated Shampoo market in 2020, with the former constituting around 36.9% share. Tinea Captis and Head Lice segments are expected to witness significant growth rates at a CAGR of 5.58% and 5.51% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 29.2% in the overall Medicated Shampoo market in 2020, and is anticipated to reach 29.6% by 2029.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook